Grannum Sant joins RxC with over 25 years’ industry experience. As a Senior Advisor, Grannum is sought after for his sage advice and experience on topics related to rare diseases, oncology, urology, biotechnology and clinical trials. Grannum is regularly involved with RXC as a subject matter expert. He has a long and established track record of bringing experience, and strategic focus to every situation. As a biopharmaceutical physician, Grannum provides a significant advantage around treatment development opportunities, new product commercialization, and regulations and compliance in life sciences.

Grannum has led many organizations in the areas of Medical Affairs, Oncology, and Urology. Prior to his relationship with RxC, Grannum consulted for Dicerna pharmaceuticals. During his extensive career Grannum was Senior Director, VP and Head, or Medical Director at OPKO Health, Genzyme, Sanofi US, Sanofi Aventis, and Sanofi Synthelabo. Grannum is a Professor at Tufts University School of Medicine.

Grannum holds the following degrees, distinctions and honors. B.A. in History; M.B., B.Ch., B.A.O. with honors in Medicine; and Doctor of Medicine (M.D.) from Trinity College, Dublin, Ireland. Residencies at Albert Einstein College of Medicine of Yeshiva University in General Surgery; and Tufts University School of Medicine in Urology. He holds an FRCS from Royal College of Surgeons in General Surgery.